Chronic Widespread Pain in HIV: Novel Mechanisms and Therapeutics
NCT04787848
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
To determine if decreased production or release of endogenous opioid peptides by peripheral immune cells contributes to hypersensitivity in people with HIV
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Chronic Widespread Pain
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 19 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Florida International University
- Last updated on ClinicalTrials.gov
- September 11, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Florida · 1
- Ambulatory Care Center, Florida International University · Miami, FL
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.